According to MoonLake Immunotherapeutics's latest financial reports and stock price the company's current number of shares outstanding is 64,463,889. At the end of 2025 the company had 63,369,984 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.